Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Cost-effectiveness of low dose CT scan screening for lung cancer in New Zealand

Principal Investigator
Name
Peter Sandiford
Degrees
M.B.Ch.B., Ph.D., M.Sc., M.Med.Sci.
Institution
Waitemata District Health Board
Position Title
Public Health Physician
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-566
Initial CDAS Request Approval
Sep 9, 2019
Title
Cost-effectiveness of low dose CT scan screening for lung cancer in New Zealand
Summary
The project applies a cost-effectiveness model to the economic evaluation of lung cancer screening in New Zealand. In particular it aims to explore a range of assumptions about the efficacy of the intervention, the nature of the population to be screened (New Zealand Maori and non-Maori), and elements of the screening programme (frequency, costs etc).
Aims

To calculate the incremental cost-effectiveness of lung cancer screening in New Zealand Maori and non-Maori men and women.
To determine the sensitivity of the incremental cost-effectiveness estimates to the assumptions inherent in the model.
To provide the government of New Zealand and key health sector stakeholders with information that will help them determine the potential value of a screening programme for lung cancer in this country, and the specific subpopulations that it would be most likely to benefit.

Collaborators

Dr Sue Crengle
Dr Karen Bartholomew
Dr Melissa McCleod
Dr Giorgi Kvizhinadze